Skip to main content
. 2018 Jun 15;9(46):28240–28266. doi: 10.18632/oncotarget.25080

Table 3. Risk of bias in studies.

Study ID Random sequence generation Allocation concealment Blinding of participants Blinding of outcome assessment Incomplete outcome data Selective reporting Other sources of bias
Scahill, 2001 U U L U U U L
Cummings, 2002 U L L U U U L
Goetz,1987 U U U U L U U
Leckman,1991 U U U U H U L
Du,2008 L U L L U U L
Singer,1994 U U U U L U U
Zhong,2007 L U U L U U L
Niederhofer,2003 U U U L U U U
Hedderick, 2009 U U L L L U L
Kurlan,1991 U U U U U U U
Smith-hicks,2007 L U U U L U U
Jankovic, 2010 L U U U L U U
Scahill,1997 U U L U L U L
George,1993 U U U L L U U
Spencer,2002 U L U U U U L
Feigin, 1995 L U U U U U L
Shapiro, 1989 U U U U L L U
Sallee, 1997 U L U U L U U
Shapirc,1984 U U U U L L U
Sallee, 1999 U U U U U H U
Scahill, 2003 L L U U L U U
Dion, 2002 U U U U L L U
Gaffney,2002 U U U U L L U
Gilbert,2004 L L L L L L U
Yoo,2013 U U U U L U L
Ghanizadeh,2014 L U L L L U L
Eggers,1988 U U U U U U L
Onofrj, 2000 L U U U L L U
Muller-vahl,2002 U L L L L U U
Gadow,1995 U U U U U U L
Gadow,1999 U U U U U U L
Gadow,2007 U L U U U U L
Castellanos,1997 U U U U U U L
Kurlan,2002 L L L U L U L
Silver, 2001 U U U U U U L
Gilbert, 2003 U U L U H U U
Gilbert, 2000 L L L U L U L
Kurlan,2012 U U U U H U L
Goetz,1994 U U U L U U U
Singer, 2001 L U L U U U H
Lemmon,2015 L U L U U U U
Bloch,2016 U L L L U U U
Allen,2005 L U U U L U L
Spencer,2008 U U U U H U L
Silver,2001 L L L U H U L
Mcconville,1992 U U U U L U L
Zhao,2010 U L L L L L U
Zheng,2016 U U L U L L L
Li, 2009 L U U U L L U
Wu,2010 U U U U U U U
Wu,2009 L U U U U L U
Toran,2005 U U U U U U H
Nicolson,2005 U U U U L U L

Note: H: high risk; L:low risk; U:unclear